Developer of a biotechnology platform intended to synthesize DNA molecules. The company's platform uses lyophilized for DNA replication and usually works in pairs to create two identical DNA strands from a single original DNA molecule, enabling doctors to perform DNA testing in the field of DNA.
What you see here scratches the surfaceRequest a free trial
We’ll help you find what you needLearn more
|Deal Type||Date||Amount||Raised to Date||Post-Val||Status||Stage|
|2. Bankruptcy: Liquidation||01-Feb-2013||Completed||Bankruptcy: Liquidation|
|1. Early Stage VC||19-Jun-2007||Completed||Generating Revenue|